{"filing":{"accession_number":"0001425450-26-000066","cik":"0001425450","ticker":"KIDS","company_name":"ORTHOPEDIATRICS CORP","form":"8-K","filing_date":"2026-08-04","report_date":"2026-08-04","primary_document":"kids-20260804.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545026000066/kids-20260804.htm"},"events":[{"id":23953,"run_id":21665,"accession_number":"0001425450-26-000066","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"OrthoPediatrics issued a press release on August 4, 2026, announcing its Q2 2026 financial results, including record revenue of $70.5 million (up 15% YoY), record adjusted EBITDA of $6.8 million, and increased full-year 2026 guidance to $265.0–$269.0 million. The filing explicitly states the press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The disclosure includes unaudited condensed consolidated financial statements and detailed segment performance metrics.","company_name":"ORTHOPEDIATRICS CORP","ticker":"KIDS","filing_date":"2026-08-04","form":"8-K","submitted_at":null,"items":[{"id":24318,"accession_number":"0001425450-26-000066","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"OrthoPediatrics issued a press release on August 4, 2026, announcing its Q2 2026 financial results, including record revenue of $70.5 million (up 15% YoY), record adjusted EBITDA of $6.8 million, and increased full-year 2026 guidance to $265.0–$269.0 million. The filing explicitly states the press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The disclosure includes unaudited condensed consolidated financial statements and detailed segment performance metrics.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T02:33:38.471614+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":24318,"accession_number":"0001425450-26-000066","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"OrthoPediatrics issued a press release on August 4, 2026, announcing its Q2 2026 financial results, including record revenue of $70.5 million (up 15% YoY), record adjusted EBITDA of $6.8 million, and increased full-year 2026 guidance to $265.0–$269.0 million. The filing explicitly states the press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The disclosure includes unaudited condensed consolidated financial statements and detailed segment performance metrics.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T02:33:38.471614+00:00","company_name":"ORTHOPEDIATRICS CORP","ticker":"KIDS","filing_date":"2026-08-04"}]}